Specimen Bags vs Biohazard Bags: Key Differences for Canadian Medical Labs

July 29, 2026

Specimen Bags vs Biohazard Bags: Key Differences for Canadia

Defining Specimen Bags

Specimen bags are specialized containers designed for the safe transport of biological specimens collected for diagnostic testing. Canadian medical laboratories rely on these bags to maintain sample integrity from the point of collection to the testing facility. Typically constructed from durable, leak-resistant materials, specimen bags often feature a self-sealing closure and a separate pocket for paperwork to prevent contamination between the requisition form and the sample itself. CliniEco's self-sealing specimen bags, for example, are manufactured from PLA-biodegradable materials, combining functionality with environmental responsibility.

Defining Biohazard Bags

Biohazard bags serve a distinct purpose: the containment and disposal of regulated medical waste. These bags are clearly marked with the universal biohazard symbol and are used for items contaminated with potentially infectious materials, such as used PPE, contaminated lab consumables, and waste generated during specimen processing. Biohazard bags are categorized by colour — red or orange being most common — to signal their contents and disposal requirements. CliniEco's 30-gallon red biohazard waste bags provide a reliable containment solution for Canadian labs, also available in a PLA-biodegradable formulation.

Canadian Regulatory Frameworks: TDG, PHAC, and CSA Z316.5

Understanding the regulatory landscape is essential for Canadian medical labs. The Transportation of Dangerous Goods (TDG) Regulations govern the shipment of biological substances across Canada. Under TDG, diagnostic specimens are classified as Category B (UN 3373) and must be packaged in a triple-layer system: a primary leak-proof container, a secondary leak-proof container, and a rigid outer packaging. Specimen bags typically serve as the secondary containment layer in this system.

The Public Health Agency of Canada (PHAC) provides guidelines through the Human Pathogens and Toxins Act and the Canadian Biosafety Standard, which dictate how biological materials are handled, stored, and disposed of within laboratory settings. PHAC guidelines direct labs to segregate waste at the source — a practice that directly determines when specimen bags versus biohazard bags should be used.

Additionally, CSA Z316.5 is the Canadian standard specifying performance requirements for commercial biohazard containment equipment and supplies. This standard covers aspects such as puncture resistance, leak-proof integrity, and label durability for bags used in biohazard waste containment, ensuring that products meet consistent safety benchmarks across the industry.

When to Use Specimen Bags vs Biohazard Bags

The distinction is straightforward but critical. Use specimen bags when transporting diagnostic samples — blood, urine, tissue, swabs — from collection sites to the laboratory for analysis. These bags are part of the transport chain, not the disposal chain. Use biohazard bags for waste materials that have come into contact with biological hazards and are destined for treatment or disposal. Cross-contamination occurs when labs use biohazard bags for specimen transport (lacking the necessary paperwork compartments and proper secondary containment design) or use specimen bags for waste disposal (which may not meet the puncture-resistance and colour-coding requirements of CSA Z316.5).

Specimen Bags vs Biohazard Bags: Key Differences for Canadia

Labeling Requirements

Specimen bags must be labelled with the patient identifier, specimen type, collection date and time, and the requesting physician's information. When transported off-site, they must also carry the UN 3373 mark and the appropriate TDG shipping name. Biohazard bags must display the universal biohazard symbol, the word "Biohazard," the waste category, and the generator's information. Both bag types should be labelled before filling to avoid disturbing their contents.

Transport Considerations

Specimen transport in Canada involves strict compliance with TDG Part 1 (Interpretation) and Part 4 (Dangerous Goods Safety Marks). Specimen bags must be placed within a rigid outer container with absorbent material sufficient to contain the full volume of the primary container. Temperature control may also be required depending on the analyte stability. Biohazard bags designated for waste transport must be placed in rigid, leak-proof containers and handled by licensed waste management carriers. Mixing the two categories can result in regulatory non-compliance, fines, and potential biosafety incidents.

Cost Implications

While specimen bags and biohazard bags may appear similar at first glance, their cost structures differ. Specimen bags are generally lower in unit cost but are consumed in higher volumes due to the frequency of diagnostic testing. Biohazard bags incur additional costs related to waste disposal fees, treatment charges (autoclaving or incineration), and regulatory documentation. Choosing the correct bag for each application not only ensures compliance with Canadian regulations but also prevents unnecessary expenditures associated with improper segregation, fines, and reprocessing of misidentified samples.

Making the Right Choice for Your Lab

Canadian medical laboratories benefit from a clear, documented policy on bag selection that aligns with TDG requirements, PHAC biosafety guidelines, and CSA standards. CliniEco offers both PLA-biodegradable specimen bags and red biohazard waste bags designed to meet these regulatory demands while supporting sustainability goals. For procurement teams evaluating medical lab supplies, understanding the distinction between these two bag types is an effective step toward safer, more compliant laboratory operations.